Vaccines to Breast Cancer Based on P53 Mutants.

doi 10.21236/ada359979
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Designing Vaccines to Prevent Breast Cancer Recurrence or Invasive Disease

Immunotherapy
OncologyAllergyImmunology
2015English

Developing Anti-Her2 Vaccines: Breast Cancer Experience

International Journal of Cancer
Cancer ResearchOncology
2018English

Gain-Of-Function P53 Mutants Co-Opt Chromatin Pathways to Drive Cancer Growth

Nature
Multidisciplinary
2015English

Transcriptional Functionality of Germ Line P53 Mutants Influences Cancer Phenotype

Clinical Cancer Research
Cancer ResearchOncology
2007English

RNA-Based Vaccines in Cancer Immunotherapy

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Gain of Oncogenic Function of P53 Mutants Induces Invasive Phenotypes in Human Breast Cancer Cells by Silencing CCN5/WISP-2

Cancer Research
Cancer ResearchOncology
2008English

PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Genetic Basis for P53 Overexpression in Human Breast Cancer.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy